Skip to main content
. 2023 Mar 31;2023(3):CD011006. doi: 10.1002/14651858.CD011006.pub4

NCT04818099.

Study name Vortioxetine in the treatment of depression associated with head and neck cancers undergoing radiotherapy
Methods  
Participants  
Interventions Vortioxetine 10 mg vs placebo
Outcomes  
Starting date 10 October 2020
Contact information  
Notes  

RCT: randomised controlled trial.